Accelerated Clinical Trial AgreementTrial Agreement • May 15th, 2019
Contract Type FiledMay 15th, 2019This Accelerated Clinical Trial (ACTA) Agreement (“Agreement”) is made as of this {DAY} day of {MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME}, a non-profit, educational, research and healthcare institution (“Institution”) with an address at {INSTITUTION ADDRESS} and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS}(“Sponsor”). Sponsor and Institution are herein referred to collectively as “Parties.” Individually, each of Sponsor and Institution is a “Party.”
ContractTrial Agreement • October 27th, 2014
Contract Type FiledOctober 27th, 2014[The Accelerated Clinical Trial Agreement (ACTA) was developed to create a standard agreement to accelerate the contracting process between Sponsors and entities registered to use the ACTA. When drafting the ACTA, the entities involved brought to the discussion extensive knowledge from negotiations between Industry and university and academic medical center partners. Based on those negotiations, the language is intended to provide the optimal compromise position for both Parties. Although the ACTA is intended for multi-center clinical trials, the parties who have agreed to its terms should feel free to use it at their discretion for other types of sponsor-initiated clinical trials. This agreement has also been designed for use as a training tool for Industry Sponsors and their corresponding university/academic medical center partners. Therefore, comments have been added to clarify the specific language. The entities involved in the development of the ACTA made several concessions with